NCT00406380

Effect of Avastin in Juxtafoveal Telangiectasias

Does Avastin Change Evolution in Juxtafoveal Telangiectasias?

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Asociación para Evitar la Ceguera en México · Academic / Other
• Sex: All
• Age: 40 Years – 70 Years
• Healthy volunteers: —

Summary

Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients with Yuxtafoveal Telangiectasias

Detailed description

After diagnose Yuxtafoveal telangiectasias secondary to Branch Retinal Vein Occlusion and with Idiopathic Ethiology by clinical signs and Fluorescein angiogram (FA)findings we treated patients with Intravitreal Injection of Bevacizumab (2.5mg/0.1ml). We performed a complete ophthalmological evaluation and at baseline and follow-up (1 and 3 months) we evaluate ETDRS Best Corrected visual acuity (BCVA), fluorescein angiogram (FA) and Optical Coherence Tomography (OCT)findings. We found an improvement in visual acuity and reduction of FA leakage and decrease retinal thickness in OCT.

Conditions

• Telangiectasis

Interventions

Type	Name	Description
DRUG	Bevacizumab
PROCEDURE	Intravitreal injection of Bevacizumab

Timeline

• Start date: 2006-09-01
• Primary completion: 2006-09-01
• Completion: 2006-11-01
• First posted: 2006-12-04
• Last updated: 2024-05-30

Locations

1 site across 1 country: Mexico